Non-Transparent PBMs Drive Drug Pricing Up

Newscat

Non-transparent PBMs are driving out independent and community pharmacies with lower reimbursements at the expense of patients, Plan Sponsors, and taxpayers.

Non-transparent PBMs drive up the cost of drug spend for Plan Sponsors.

Plan Sponsors and stakeholders need to focus on negotiating and executing cost-containment through better contracting.

Plan Sponsors must force PBMs to abide by Federal/State laws as well as contract terms.